Pulmonary hypertension in well-transfused thalassemia major patients
- PMID: 25488617
- PMCID: PMC4297514
- DOI: 10.1016/j.bcmd.2014.11.003
Pulmonary hypertension in well-transfused thalassemia major patients
Abstract
The risk for pulmonary hypertension (PH) in thalassemia major (TM) patients remains controversial. We report echocardiography results from 60 TM patients: we evaluated the association between tricuspid regurgitation velocities (TRV), iron stores, and serologic markers of hemolysis and arginine dysregulation. Patients were enrolled from August 2004 until May 2009. All parameters were inversely weighted by the number of exams. TRV was comparable between sexes and it was uncorrelated with age. At the first exam, TR velocities at the upper limits of normal (2.5-2.7m/s) were observed in 8 patients. An abnormal TRV (2.9m/s) was found in 1 patient. Borderline increases in TRV were associated with a reduced global arginine bioavailability (R=-0.399 P=0.005), increased anemia (hemoglobin: R=-0.219 P=0.0461), cardiac index (R=0.223 P=0.0481), and diastolic dysfunction (E/A: R=0.289 P=0.0088; E/E': R=0.223 P=0.0453), but not hemolysis, iron overload and systolic function evaluated by Magnetic Resonance Imaging, and splenectomy. Well-transfused TM patients have a lower risk for PH than thalassemia intermedia patients. However, they do have vascular stressors that raise their lifetime PH risk to levels higher than for the general population. Consequently, we support recommendations for annual echocardiographic screening and cardiac catheterization for persistent TRV above 3m/s.
Keywords: Echocardiography; Risk for pulmonary hypertension; Thalassemia major; Tricuspid regurgitant jet velocity.
Copyright © 2014 Elsevier Inc. All rights reserved.
Conflict of interest statement
Dr Pepe has received speaker honoraria from Chiesi Farmaceutici, ApoPharma Inc. and Novartis. Dr. Harmatz has received research funding, honorarium and/or provided consulting support to Shire, BioMarin, Alexion, Novartis, and Genzyme. Dr Wood and Dr Coates receive research funding from Shire. Dr Wood is MRI consultant for Shire, Biomed Informatics, and ApoPharma.
Figures



Similar articles
-
Asymmetric dimethylarginine levels in children with β-thalassemia and their correlations to tricuspid regurgitant jet velocity.Pediatr Blood Cancer. 2014 Sep;61(9):1540-3. doi: 10.1002/pbc.25076. Epub 2014 Apr 21. Pediatr Blood Cancer. 2014. PMID: 24753210
-
Pulmonary Hypertension in Children With β Thalassemia Major, Are Splenectomy and High-Ferritin Levels Related or Not?J Pediatr Hematol Oncol. 2017 May;39(4):259-265. doi: 10.1097/MPH.0000000000000803. J Pediatr Hematol Oncol. 2017. PMID: 28234742
-
Platelet hyperactivity in thalassemia patients with elevated tricuspid regurgitant velocity and the association with hemolysis.Thromb Res. 2015 Jan;135(1):121-6. doi: 10.1016/j.thromres.2014.10.010. Epub 2014 Oct 18. Thromb Res. 2015. PMID: 25455999
-
Pulmonary hypertension associated with thalassemia syndromes.Ann N Y Acad Sci. 2016 Mar;1368(1):127-39. doi: 10.1111/nyas.13037. Epub 2016 Mar 23. Ann N Y Acad Sci. 2016. PMID: 27008311 Free PMC article. Review.
-
Pulmonary hypertension in beta-thalassemia.Ann N Y Acad Sci. 2005;1054:342-9. doi: 10.1196/annals.1345.041. Ann N Y Acad Sci. 2005. PMID: 16339682 Review.
Cited by
-
Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia.J Clin Med. 2024 Feb 23;13(5):1281. doi: 10.3390/jcm13051281. J Clin Med. 2024. PMID: 38592121 Free PMC article.
-
Splenectomy is significantly associated with thrombosis but not with pulmonary hypertension in patients with transfusion-dependent thalassemia: a meta-analysis of observational studies.Front Med (Lausanne). 2023 Oct 11;10:1259785. doi: 10.3389/fmed.2023.1259785. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37886361 Free PMC article.
-
Real-world complication burden and disease management paradigms in transfusion-related β-thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross-sectional study.EJHaem. 2023 May 23;4(3):569-581. doi: 10.1002/jha2.695. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601860 Free PMC article.
-
Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.Radiol Med. 2024 Jun;129(6):879-889. doi: 10.1007/s11547-024-01821-y. Epub 2024 Apr 29. Radiol Med. 2024. PMID: 38683500
-
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.Br J Haematol. 2015 Jun;169(6):887-98. doi: 10.1111/bjh.13452. Epub 2015 Apr 24. Br J Haematol. 2015. PMID: 25907665 Free PMC article.
References
-
- McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006;114:1417–1431. - PubMed
-
- Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6:359–365. - PubMed
-
- Barnett CF, Hsue PY, Machado RF. Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection. Jama. 2008;299:324–331. - PubMed
-
- Aessopos A, Farmakis D. Pulmonary hypertension in beta-thalassemia. Ann N Y Acad Sci. 2005;1054:342–349. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical